Literature DB >> 10544506

Keyhole limpet hemocyanin (KLH): a biomedical review.

J R Harris1, J Markl.   

Abstract

In this review we present a broad survey of fundamental scientific and medically applied studies on keyhole limpet hemocyanin (KLH). Commencing with the biochemistry of KLH, information on the biosynthesis and biological role of this copper-containing respiratory protein in the marine gastropod Megathura crenulata is provided. The established methods for the purification of the two isoforms of KLH (KLH1 and KLH2) are then covered, followed by detailed accounts of the molecular mass determination, functional unit (FU) structure, carbohydrate content, immunological analysis and recent aspects of the molecular genetics of KLH. The transmission electron microscope (TEM) has contributed significantly to the understanding of KLH structure, primarily from negatively stained images. We give a brief account of TEM studies on the native KLH oligomers, the experimental manipulation of the oligomeric states, together with immunolabelling data and studies on subunit reassociation. The field of cellular immunology has provided much relevant biomedical information on KLH and has led to the expansion of use of KLH in experimental immunology and clinically as an immunotherapeutic agent; this area is presented in some detail. The major clinical use of KLH is specifically for the treatment of bladder carcinoma, with efficacy probably due to a cross-reacting carbohydrate epitope. KLH also has considerable possibilities for the treatment of other carcinomas, in particular the epithelially derived adenocarciomas, when used as a carrier for carcinoma ganglioside and mucin-like epitopes. The widespread use of KLH as a hapten carrier and generalised vaccine component represent other major on-going aspects of KLH research, together with its use for the diagnosis of Schistosomiasis, drug assay and the treatment of drug addiction. Immune competence testing, assessment of stress and the understanding of inflammatory conditions are other areas where KLH is also making a useful contribution to medical research.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10544506     DOI: 10.1016/s0968-4328(99)00036-0

Source DB:  PubMed          Journal:  Micron        ISSN: 0968-4328            Impact factor:   2.251


  82 in total

1.  Immunological investments reflect parasite abundance in island populations of Darwin's finches.

Authors:  Karin M Lindström; Johannes Foufopoulos; Henrik Pärn; Martin Wikelski
Journal:  Proc Biol Sci       Date:  2004-07-22       Impact factor: 5.349

2.  Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug delivery.

Authors:  Yuan Lu; Wei Chan; Benjamin Y Ko; Christopher C VanLang; James R Swartz
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-21       Impact factor: 11.205

3.  Conformational states of the Rapana thomasiana hemocyanin and its substructures studied by dynamic light scattering and time-resolved fluorescence spectroscopy.

Authors:  Dessislava Georgieva; Daniel Schwark; Peter Nikolov; Krassimira Idakieva; Katja Parvanova; Karsten Dierks; Nicolay Genov; Christian Betzel
Journal:  Biophys J       Date:  2004-11-08       Impact factor: 4.033

4.  Synthesis of double C-glycoside analogue of sTn.

Authors:  Dino K Ress; Sultan N Baytas; Qun Wang; Eva M Muñoz; Kazuo Tokuzoki; Hiroshi Tomiyama; Robert J Linhardt
Journal:  J Org Chem       Date:  2005-09-30       Impact factor: 4.354

5.  Induction of humoral immune response in piglets after perinatal or post-weaning immunization against porcine circovirus type-2 or keyhole limpet hemocyanin.

Authors:  Jessica Law; Robert McCorkell; Greg Muench; Katherine Wynne-Edwards; Hermann M Schaetzl; Cristina Solis; Narges Nourozieh; Regula Waeckerlin; Michael Eschbaumer; Shawn Horsman; Markus Czub
Journal:  Can J Vet Res       Date:  2017-01       Impact factor: 1.310

6.  Primary immune response to keyhole limpet haemocyanin following trauma in relation to low plasma glutamine.

Authors:  P G Boelens; J C M Fonk; A P J Houdijk; R J Scheper; H J T H M Haarman; S Meijer; P A M Van Leeuwen; B M E von Blomberg-van der Flier
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

7.  A nanoparticle-based nicotine vaccine and the influence of particle size on its immunogenicity and efficacy.

Authors:  Zongmin Zhao; Yun Hu; Reece Hoerle; Meaghan Devine; Michael Raleigh; Paul Pentel; Chenming Zhang
Journal:  Nanomedicine       Date:  2016-08-09       Impact factor: 5.307

8.  Positions of the glycans in molluscan hemocyanin, determined by fluorescence spectroscopy.

Authors:  Elena Kostadinova; Pavlina Dolashka; Lyudmila Velkova; Aleksandar Dolashki; Stefan Stevanovic; Wolfgang Voelter
Journal:  J Fluoresc       Date:  2013-03-15       Impact factor: 2.217

9.  The next-generation nicotine vaccine: a novel and potent hybrid nanoparticle-based nicotine vaccine.

Authors:  Yun Hu; Daniel Smith; Evan Frazier; Reece Hoerle; Marion Ehrich; Chenming Zhang
Journal:  Biomaterials       Date:  2016-08-18       Impact factor: 12.479

10.  Evaluation of two carrier protein-angiotensin I conjugate vaccines to assess their future potential to control high blood pressure (hypertension) in man.

Authors:  M R Downham; T R Auton; A Rosul; H L Sharp; L Sjöström; A Rushton; J P Richards; T G K Mant; S M Gardiner; T Bennett; J F Glover
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.